NEW YORK (GenomeWeb News) – Affymetrix said after the close of the market on Monday that it has given notice of its intention to redeem all of its outstanding 3.50 percent senior convertible notes due 2038.

Affy will redeem the notes on Jan. 15, 2013. As of Nov. 15, there was about $3.9 million aggregate principal amount of the convertible notes outstanding. The notes will be redeemed at a redemption price of 100 percent of the principal amount of the convertible notes redeemed, plus accrued and unpaid interest up to but not including the redemption date.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.